All Clinical Trials
View all active clinical trials around the US.
Randomized Phase 2 Study of Iberdomide Maintenance Therapy Following Idecabtagene Vicleucel CAR-T in Multiple Myeloma Patients
IBERDOMIDE VS. OBSERVATION POST IDE-CEL CAR-T
Blinded Reference Set for Multicancer Early Detection Blood Tests
EARLY DETECTION BLOOD TESTS
Untreated / Newly Diagnosed Multiple Myeloma
The following is a listing of clinical trials for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.
Blinded Reference Set for Multicancer Early Detection Blood Tests
EARLY DETECTION BLOOD TESTS
Late Relapse Multiple Myeloma
The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.
Randomized Phase 2 Study of Iberdomide Maintenance Therapy Following Idecabtagene Vicleucel CAR-T in Multiple Myeloma Patients
IBERDOMIDE VS. OBSERVATION POST IDE-CEL CAR-T
Smoldering Myeloma
No active clinical trials
Monoclonal Gammopathy of Undetermined Significance (MGUS)
No active clinical trials